• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管内皮生长因子C在子宫内膜异位症中的表达及抗血管生成治疗

Expression of vascular endothelial growth factor C and anti-angiogenesis therapy in endometriosis.

作者信息

Song Wei-Wei, Lu Huan, Hou Wen-Jing, Xu Guang-Xu, Zhang Ji-Hong, Sheng You-Hua, Cheng Ming-Jun, Zhang Rong

机构信息

Medical College of Soochow University Shanghai 215123, P. R. China ; Department of Obstetrics and Gynecology, Shanghai Jiaotong University Affiliated Sixth People Hospital South Campus Shanghai 201499, P. R. China.

Department of Obstetrics and Gynecology, Shanghai Jiaotong University Affiliated Sixth People Hospital South Campus Shanghai 201499, P. R. China.

出版信息

Int J Clin Exp Pathol. 2014 Oct 15;7(11):7752-9. eCollection 2014.

PMID:25550812
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4270624/
Abstract

Angiogenesis is an important pathogenesis of Endometriosis. Vascular endothelial growth factor C (VEGF-C) is one of the most important factor in the regulation of both normal and abnormal angiogenesis. Anti-angiogenic treatment of endometriosis is still in the exploratory stage. In this study, we investigate the relationship between VEGF-C and endometriosis, the therapeutic effects of Endostar in the rat endometriosis model. We then demonstrated that Immunohistochemical expression of VEGF-C was higher in endometriotic tissues than in control normal ovary tissues (P < 0.01) and higher in the endomertriosis grade III-IV than in endomertriosis grade I-II (P=0.013). In rat endometriosis model, we observed a significant reduction in the mean volume and weight of the endometriotic implants per rat in the treatment group as compared with the control group. By immunohistochemical evaluation, there was a significant reduction in VEGF-C expression after treatment in all areas examined. VEGF-C may be involved in the pathogenesis of endomertriosis by regulating the angiogenesis. Endostar has therapeutic effects of endometriosis lesions in the rat endometriosis model.

摘要

血管生成是子宫内膜异位症的重要发病机制。血管内皮生长因子C(VEGF-C)是调节正常和异常血管生成的最重要因子之一。子宫内膜异位症的抗血管生成治疗仍处于探索阶段。在本研究中,我们研究了VEGF-C与子宫内膜异位症之间的关系,以及恩度在大鼠子宫内膜异位症模型中的治疗效果。然后我们证明,VEGF-C在异位内膜组织中的免疫组化表达高于对照正常卵巢组织(P<0.01),在III-IV期子宫内膜异位症中高于I-II期子宫内膜异位症(P=0.013)。在大鼠子宫内膜异位症模型中,我们观察到与对照组相比,治疗组每只大鼠异位内膜植入物的平均体积和重量显著降低。通过免疫组化评估,在所有检查区域治疗后VEGF-C表达均显著降低。VEGF-C可能通过调节血管生成参与子宫内膜异位症的发病机制。恩度对大鼠子宫内膜异位症模型中的异位症病变有治疗作用。

相似文献

1
Expression of vascular endothelial growth factor C and anti-angiogenesis therapy in endometriosis.血管内皮生长因子C在子宫内膜异位症中的表达及抗血管生成治疗
Int J Clin Exp Pathol. 2014 Oct 15;7(11):7752-9. eCollection 2014.
2
Vascular endothelial growth factor C is increased in endometrium and promotes endothelial functions, vascular permeability and angiogenesis and growth of endometriosis.血管内皮生长因子 C 在子宫内膜中增加,并促进内皮功能、血管通透性和血管生成以及子宫内膜异位症的生长。
Angiogenesis. 2013 Jul;16(3):541-51. doi: 10.1007/s10456-013-9333-1. Epub 2013 Jan 19.
3
Effect of pentoxifylline on vascular endothelial growth factor C and flk-1 expression on endometrial implants in the rat endometriosis model.己酮可可碱对子宫内膜异位症大鼠模型中子宫内膜种植灶血管内皮生长因子 C 和 flk-1 表达的影响。
Fertil Steril. 2010 Mar 1;93(4):1316-23. doi: 10.1016/j.fertnstert.2008.10.056. Epub 2009 Jan 14.
4
Vascular endothelial growth factor A and C gene expression in endometriosis.血管内皮生长因子A和C在子宫内膜异位症中的基因表达
Hum Pathol. 2004 Nov;35(11):1369-75. doi: 10.1016/j.humpath.2004.07.020.
5
MicroRNA expression profile in endometriosis: its relation to angiogenesis and fibrinolytic factors.子宫内膜异位症中的微小RNA表达谱:其与血管生成及纤溶因子的关系
Hum Reprod. 2014 May;29(5):978-88. doi: 10.1093/humrep/deu019. Epub 2014 Mar 6.
6
The relationship between microvessel density, proliferative activity and expression of vascular endothelial growth factor-A and its receptors in eutopic endometrium and endometriotic lesions.在位内膜和子宫内膜异位症病灶中微血管密度、增殖活性与血管内皮生长因子-A及其受体表达之间的关系
Reproduction. 2006 Sep;132(3):501-9. doi: 10.1530/rep.1.01110.
7
Green tea epigallocatechin-3-gallate inhibits angiogenesis and suppresses vascular endothelial growth factor C/vascular endothelial growth factor receptor 2 expression and signaling in experimental endometriosis in vivo.绿茶表没食子儿茶素-3-没食子酸酯通过抑制血管内皮生长因子 C/血管内皮生长因子受体 2 的表达和信号通路抑制实验性子宫内膜异位症的血管生成。
Fertil Steril. 2011 Oct;96(4):1021-8. doi: 10.1016/j.fertnstert.2011.07.008. Epub 2011 Aug 6.
8
Pregnancy affects morphology of induced endometriotic lesions in a mouse model through alteration of proliferation and angiogenesis.在小鼠模型中,妊娠通过改变增殖和血管生成来影响诱导性子宫内膜异位病变的形态。
Eur J Obstet Gynecol Reprod Biol. 2014 Dec;183:70-7. doi: 10.1016/j.ejogrb.2014.10.038. Epub 2014 Oct 30.
9
NME1 suppression of endometrial stromal cells promotes angiogenesis in the endometriotic milieu via stimulating the secretion of IL-8 and VEGF.NME1对子宫内膜间质细胞的抑制作用通过刺激IL-8和VEGF的分泌促进了子宫内膜异位症环境中的血管生成。
Int J Clin Exp Pathol. 2013 Sep 15;6(10):2030-8. eCollection 2013.
10
A potential novel treatment strategy: inhibition of angiogenesis and inflammation by resveratrol for regression of endometriosis in an experimental rat model.一种潜在的新型治疗策略:白藜芦醇抑制血管生成和炎症以促使实验性大鼠模型中的子宫内膜异位症消退
Gynecol Endocrinol. 2015 Mar;31(3):219-24. doi: 10.3109/09513590.2014.976197. Epub 2014 Nov 6.

引用本文的文献

1
The Endometrial Stem/Progenitor Cells and Their Niches.子宫内膜干细胞/祖细胞及其巢位
Stem Cell Rev Rep. 2024 Jul;20(5):1273-1284. doi: 10.1007/s12015-024-10725-3. Epub 2024 Apr 18.
2
Sunitinib induces primary ectopic endometrial cell apoptosis through up-regulation of STAT1 in vitro.舒尼替尼通过上调 STAT1 诱导体外异位子宫内膜细胞凋亡。
J Clin Lab Anal. 2020 Nov;34(11):e23482. doi: 10.1002/jcla.23482. Epub 2020 Aug 5.
3
Antibiotic therapy with metronidazole reduces endometriosis disease progression in mice: a potential role for gut microbiota.甲硝唑抗生素疗法可减缓小鼠子宫内膜异位症的疾病进展:肠道微生物群的潜在作用。
Hum Reprod. 2019 Jun 4;34(6):1106-1116. doi: 10.1093/humrep/dez041.
4
Therapeutic Approaches of Resveratrol on Endometriosis via Anti-Inflammatory and Anti-Angiogenic Pathways.白藜芦醇通过抗炎和抗血管生成途径治疗子宫内膜异位症的方法。
Molecules. 2019 Feb 13;24(4):667. doi: 10.3390/molecules24040667.
5
Anti-Angiogenic Alternative and Complementary Medicines for the Treatment of Endometriosis: A Review of Potential Molecular Mechanisms.用于治疗子宫内膜异位症的抗血管生成替代和补充药物:潜在分子机制综述
Evid Based Complement Alternat Med. 2018 Oct 1;2018:4128984. doi: 10.1155/2018/4128984. eCollection 2018.
6
Efficacy of Anti-VEGF/VEGFR Agents on Animal Models of Endometriosis: A Systematic Review and Meta-Analysis.抗VEGF/VEGFR药物治疗子宫内膜异位症动物模型的疗效:系统评价与Meta分析
PLoS One. 2016 Nov 17;11(11):e0166658. doi: 10.1371/journal.pone.0166658. eCollection 2016.

本文引用的文献

1
Vascular endothelial growth factor C is increased in endometrium and promotes endothelial functions, vascular permeability and angiogenesis and growth of endometriosis.血管内皮生长因子 C 在子宫内膜中增加,并促进内皮功能、血管通透性和血管生成以及子宫内膜异位症的生长。
Angiogenesis. 2013 Jul;16(3):541-51. doi: 10.1007/s10456-013-9333-1. Epub 2013 Jan 19.
2
Anti-angiogenic treatment strategies for the therapy of endometriosis.抗血管生成治疗策略在子宫内膜异位症治疗中的应用。
Hum Reprod Update. 2012 Nov-Dec;18(6):682-702. doi: 10.1093/humupd/dms026. Epub 2012 Jun 19.
3
Endometriosis: diagnosis and management.子宫内膜异位症:诊断与管理
J Obstet Gynaecol Can. 2010 Jul;32(7 Suppl 2):S1-32.
4
Recurrence of endometriosis and its control.子宫内膜异位症的复发及其控制。
Hum Reprod Update. 2009 Jul-Aug;15(4):441-61. doi: 10.1093/humupd/dmp007. Epub 2009 Mar 11.
5
Endometriosis.子宫内膜异位症
N Engl J Med. 2009 Jan 15;360(3):268-79. doi: 10.1056/NEJMra0804690.
6
Endogenous inhibitors of angiogenesis: a historical review.血管生成的内源性抑制剂:历史回顾
Leuk Res. 2009 May;33(5):638-44. doi: 10.1016/j.leukres.2008.11.019. Epub 2008 Dec 31.
7
Angiogenesis and antiangiogenic therapy in endometriosis.子宫内膜异位症中的血管生成与抗血管生成治疗
Microvasc Res. 2007 Sep-Nov;74(2-3):121-30. doi: 10.1016/j.mvr.2007.04.008. Epub 2007 May 6.
8
The relationship between microvessel density, proliferative activity and expression of vascular endothelial growth factor-A and its receptors in eutopic endometrium and endometriotic lesions.在位内膜和子宫内膜异位症病灶中微血管密度、增殖活性与血管内皮生长因子-A及其受体表达之间的关系
Reproduction. 2006 Sep;132(3):501-9. doi: 10.1530/rep.1.01110.
9
Vascular development in endometriosis.子宫内膜异位症中的血管发育
Angiogenesis. 2005;8(2):147-56. doi: 10.1007/s10456-005-9005-x. Epub 2005 Oct 7.
10
Vascular endothelial growth factor gene +405 C/G polymorphism is associated with susceptibility to advanced stage endometriosis.血管内皮生长因子基因+405 C/G多态性与晚期子宫内膜异位症易感性相关。
Hum Reprod. 2005 Oct;20(10):2904-8. doi: 10.1093/humrep/dei146. Epub 2005 Jun 24.